Foghorn Therapeutics Inc. Contract with Customer, Liability, Noncurrent
Foghorn Therapeutics Inc. (FHTX) had Contract with Customer, Liability, Noncurrent of $193.22 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:ContractWithCustomerLiabilityNoncurrent · last filed 2026-08-06
- 2026-06-30: Contract with Customer, Liability, Noncurrent $193.22M.
- 2026-03-31: Contract with Customer, Liability, Noncurrent $193.59M.
- 2025-12-31: Contract with Customer, Liability, Noncurrent $205.96M.
- 2025-09-30: Contract with Customer, Liability, Noncurrent $193.10M.
| Period end | Contract with Customer, Liability, Noncurrent |
|---|---|
| 2026-06-30 | $193.22M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $193.59M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $205.96M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $193.10M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $206.83M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $222.44M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $234.46M 10-K · filed 2026-03-11 |
| 2024-09-30 | $249.53M 10-Q · filed 2024-11-04 |
| 2024-06-30 | $259.50M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $266.11M 10-Q · filed 2024-05-06 |
| 2023-12-31 | $268.12M 10-K · filed 2025-03-06 |
| 2023-09-30 | $280.09M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $292.02M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $298.18M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $304.00M 10-K · filed 2024-03-07 |
| 2022-09-30 | $307.84M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $312.07M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $317.07M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $322.73M 10-K · filed 2023-03-09 |
| 2021-09-30 | $12.69M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $13.10M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $11.88M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $12.55M 10-K/A · filed 2022-08-09 |
| 2020-09-30 | $13.13M 10-Q · filed 2020-12-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |